AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

Why MCK’s failed takeover lost Sharesies a customer
Markets

Why MCK’s failed takeover lost Sharesies a customer

This former Sharesies user made bank on MCK, but is leaving the platform anyway.

Analysts eye upside in property sector as values stabilise
Property

Analysts eye upside in property sector as values stabilise

On average, listed property companies are trading at a 22% discount to NTA.

Inside Ebos’s ‘revolutionary’ $1.1 billion deal
Markets

Inside Ebos’s ‘revolutionary’ $1.1 billion deal

In 2013, Ebos swallowed a giant. Now it’s the end of an era.

Ebos’ index weight grows; NZX 50 drops 0.7%
Markets Market Close

Ebos’ index weight grows; NZX 50 drops 0.7%

The a2 Milk Company sunk about 5%.

Gregor Thompson 03 Jun 2025